Amundi’s Insmed INSM Stock Holding History

Amundi’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52M	Sell	487,525 -317,452	-39%	-$38.4M	0.01%	603
2026 Q1	$132M	Sell	804,977 -112,021	-12%	-$17.2M	0.04%	388
2025 Q4	$160M	Buy	916,998 +599,902	+189%	+$109M	0.04%	371
2025 Q3	$50.2M	Buy	317,096 +305,597	+2,658%	+$37.4M	0.02%	559
2025 Q2	$1.13M	Buy	11,499 +11,445	+21,194%	+$875K	﹤0.01%	1176
2025 Q1	$3.96K	Buy	54 +12	+29%	+$918	﹤0.01%	1924
2024 Q4	$2.76K	Buy	+42	New	+$3.02K	﹤0.01%	1968
2022 Q4	–	Sell	-4,918	Closed	-$113K	–	1940
2022 Q3	$113K	Hold	4,918	–	–	﹤0.01%	1536
2022 Q2	$114K	Hold	4,918	–	–	﹤0.01%	1428
2022 Q1	$121K	Hold	4,918	–	–	﹤0.01%	1446
2021 Q4	$116K	Sell	4,918 -2,118	-30%	-$60.6K	﹤0.01%	1552
2021 Q3	$194K	Hold	7,036	–	–	﹤0.01%	1442
2021 Q2	$200K	Buy	+7,036	New	+$209K	﹤0.01%	1376

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Amundi's INSM Position: Q2 2026 in Review

Amundi reduced its Insmed (INSM) stake by 39% in Q2 2026, selling an estimated $38.4M and leaving 487,525 shares worth $52M. The position accounts for 0.01% of the portfolio, ranked #603.

Amundi first reported a position in INSM in Q2 2021 and has held it in 13 quarters since. The position peaked at $160M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Amundi held 487,525 shares of Insmed worth $52M as of Q2 2026.
Amundi sold 317,452 Insmed shares in Q2 2026, an estimated $38.4M.
Insmed made up 0.01% of Amundi's portfolio in Q2 2026, its #603 holding.
Amundi first reported a position in Insmed in Q2 2021 and has held it in 13 quarters since.
Amundi's Insmed position peaked at $160M in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.